Insider Selling: Auna (NYSE:AUNA) Director Sells 17,574 Shares of Stock

Auna S.A. (NYSE:AUNA) Director John Wilton sold 17,574 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $4.17, for a total value of $73,283.58. Following the completion of the sale, the director owned 49,974 shares of the company’s stock, valued at $208,391.58. The trade was a 26.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Auna Trading Up 9.4%

Shares of NYSE AUNA traded up $0.39 during trading hours on Monday, reaching $4.54. The stock had a trading volume of 482,885 shares, compared to its average volume of 388,856. The company has a current ratio of 1.09, a quick ratio of 1.00 and a debt-to-equity ratio of 1.76. The firm has a market cap of $336.01 million, a price-to-earnings ratio of 17.46 and a beta of 0.82. The business’s fifty day moving average price is $5.20 and its two-hundred day moving average price is $5.01. Auna S.A. has a 52-week low of $4.09 and a 52-week high of $6.85.

Auna (NYSE:AUNA) last announced its quarterly earnings results on Friday, May 15th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.14). The firm had revenue of $336.84 million during the quarter, compared to analysts’ expectations of $320.54 million. Auna had a net margin of 1.53% and a return on equity of 16.25%. Analysts expect that Auna S.A. will post 0.81 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on AUNA shares. Zacks Research lowered Auna from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 31st. Wall Street Zen lowered Auna from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 16th. Weiss Ratings restated a “sell (d)” rating on shares of Auna in a report on Friday, March 27th. Finally, JPMorgan Chase & Co. lowered their target price on Auna from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Auna presently has an average rating of “Hold” and an average target price of $6.97.

Hedge Funds Weigh In On Auna

A number of large investors have recently made changes to their positions in the business. World Investment Advisors increased its position in shares of Auna by 19.1% during the first quarter. World Investment Advisors now owns 12,563 shares of the company’s stock worth $69,000 after purchasing an additional 2,014 shares in the last quarter. Virtu Financial LLC increased its position in shares of Auna by 43.5% during the fourth quarter. Virtu Financial LLC now owns 16,029 shares of the company’s stock worth $79,000 after purchasing an additional 4,856 shares in the last quarter. Sage Investment Counsel LLC increased its position in shares of Auna by 60.0% during the fourth quarter. Sage Investment Counsel LLC now owns 16,000 shares of the company’s stock worth $79,000 after purchasing an additional 6,000 shares in the last quarter. Citadel Advisors LLC increased its position in shares of Auna by 28.9% during the third quarter. Citadel Advisors LLC now owns 36,352 shares of the company’s stock worth $244,000 after purchasing an additional 8,147 shares in the last quarter. Finally, Bank of America Corp DE increased its position in shares of Auna by 255.9% during the first quarter. Bank of America Corp DE now owns 16,886 shares of the company’s stock worth $93,000 after purchasing an additional 12,142 shares in the last quarter.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.